Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Anticipates Humira sBLA For Crohn’s Disease By Year-End

22 May 2006

• By Jonathan Block

Application would be buoyed by new Phase III remission data.

Related Content

UCB Cimzia BLA Submission Could Provide First Subcutaneous Injection For Crohn’s

02 Mar 2006

J&amp;J/Centocor’s Remicade Gains Pediatric Crohn’s Disease Indication

15 May 2006

Humira sBLA Submitted For Ankylosing Spondylitis

04 Oct 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.